[1] Armulik A, Genové G, Betsholtz C. Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises.Developmental Cell. 2011;21(2):193-215.
[2] Leveen P, Pekny M, Gebre-Medhin S,et al. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities.Genes & development. 1994;8(16): 1875-1887.
[3] Tomkowicz B, Rybinski K, Sebeck D, et al. Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling. Cancer biology & therapy. 2010;9(11):908-915.
[4] Caplan AI. All MSCs are pericytes?. Cell stem cell. 2008;3(3): 229-230.
[5] da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem cells. 2008; 26(9):2287-2299.
[6] Corselli M, Chen CW, Crisan M,et al. Perivascular ancestors of adult multipotent stem cells. Arteriosclerosis, thrombosis, and vascular biology. 2010;30(6):1104-1109.
[7] Caplan AI, Correa D. PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J Orthop Res. 2011 Dec;29(12):1795-1803.
[8] Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell and tissue research.2003;314(1):15-23.
[9] Stratman AN, Schwindt AE, Malotte KM, et al. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood. 2010;116(22):4720-4730.
[10] Ruan J, Luo M, Wang C,et al. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood. 2013; 121(26):5192-5202.
[11] Cipriani P, Marrelli A, Benedetto PD,et al. Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. Angiogenesis. 2013;16(3):595-607.
[12] Armulik A, Mae M, Betsholtz C.Pericytes and the blood-brain barrier: recent advances and implications for the delivery of CNS therapy. Therapeutic delivery. 2011;2(4):419-22.
[13] Van Geest RJ, Klaassen I, Vogels IM,et al. Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy?. Investigative ophthalmology & visual science. 2010; 51(4):1857-1865.
[14] Goumans MJ, Valdimarsdottir G, Itoh S,et al. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. The EMBO journal. 2002;21(7):1743-53.
[15] Hill J, Rom S, Ramirez SH,et al. Emerging Roles of Pericytes in the Regulation of the Neurovascular Unit in Health and Disease. J Neuroimmune Pharmacol. 2014;9(5):591-605
[16] Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nature neuroscience. 2011; 14(11):1398-1405.
[17] Darland DC, D'Amore PA. TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis. 2001;4(1):11-20.
[18] Mercado-Pimentel ME, Runyan RB. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells, tissues, organs. 2007;185(1-3):146-156.
[19] Qin D, Trenkwalder T, Lee S,et al. Early vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia. PloS one. 2013;8(4):e61831.
[20] Jeansson M, Gawlik A, Anderson G,et al.Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest. 2011 Jun;121(6):2278-2289.
[21] Augustin HG, Koh GY, Thurston G,et al. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nature reviews Molecular cell biology. 2009;10(3): 165-177.
[22] Khairoun M, van der Pol P, de Vries DK,et al. Renal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis. Am J Physiol Renal Physiol. 2013;305(6):F901-910.
[23] Cai J, Ruan Q, Chen ZJ,et al. Connection of pericyte- angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?. Future medicinal chemistry. 2012;4(17):2163-2176.
[24] Saharinen P, Alitalo K. The yin, the yang, and the angiopoietin-1. J Clin Invest. 2011;121(6):2157-2159.
[25] Manderfield LJ, High FA, Engleka KA,et al.Notch Activation of Jagged1 Contributes to the Assembly of the Arterial Wall. Circulation.2012;125(2):314-323.
[26] Wang Q, Zhao N, Kennard S, Lilly B. Notch2 and Notch3 function together to regulate vascular smooth muscle development. PloS one. 2012;7(5):e37365.
[27] Walshe TE, Connell P, Cryan L,et al. Microvascular retinal endothelial and pericyte cell apoptosis in vitro: role of hedgehog and Notch signaling. Investigative ophthalmology & visual science. 2011;52(7):4472-83.
[28] Wang Y, Pan L, Moens CB,et al. Notch3 establishes brain vascular integrity by regulating pericyte number.Development (Cambridge, England). 2014;141(2):307-17.
[29] Yamamoto Y, Craggs L, Baumann M, et al. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathology and applied neurobiology. 2011; 37(1):94-113.
[30] Domenga V, Fardoux P, Lacombe P,et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes & development. 2004;18(22):2730-2735.
[31] Liu H, Zhang W, Kennard S,et al. Notch3 is critical for proper angiogenesis and mural cell investment. Circulation research. 2010;107(7):860-870.
[32] Gu X, Liu XY, Fagan A, Gonzalez-Toledo ME,et al. Ultrastructural changes in cerebral capillary pericytes in aged Notch3 mutant transgenic mice. Ultrastructural pathology. 2012; 36(1):48-55.
[33] Jin S, Hansson EM, Tikka S,et al.Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Circulation research. 2008;102 (12):1483-1491.
[34] Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes & development. 2001;15(23):3059-3087.
[35] Nielsen CM, Dymecki SM. Sonic hedgehog is required for vascular outgrowth in the hindbrain choroid plexus. Developmental biology. 2010;340(2):430-437.
[36] Lee SW, Moskowitz MA, Sims JR. Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts.Int J Mol Med. 2007;19(3):445-451.
[37] Song N, Huang Y, Shi H,et al. Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis. Cancer research. 2009;69(15):6057-6064.
[38] Stratman AN, Davis MJ, Davis GE.VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood. 2011;117(14): 3709-3719.
[39] Hamdan R, Zhou Z, Kleinerman ES. SDF-1alpha induces PDGF-B expression and the differentiation of bone marrow cells into pericytes. Mol Cancer Res. 2011;9(11):1462-1470.
[40] Nolan-Stevaux O, Truitt MC, Pahler JC,et al. Differential contribution to neuroendocrine tumorigenesis of parallel egfr signaling in cancer cells and pericytes. Genes & cancer. 2010;1(2):125-1241.
[41] Yu X, Radulescu A, Chen CL,et al. Heparin-binding EGF-like growth factor protects pericytes from injury. J Surg Res. 2012; 172(1):165-176.
[42] Bethani I, Skanland SS, Dikic I,et al. Spatial organization of transmembrane receptor signalling. EMBO J. 2010,29(16): 2677-2688.
[43] Foo SS, Turner CJ, Adams S,et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly.Cell. 2006;124(1):161-173.
[44] Nakayama A, Nakayama M, Turner CJ, et al. Ephrin-B2 controls PDGFRbeta internalization and signaling. Genes Development. 2013;27(23):2576-2589. |